Delivery Order SPE2DB20D2104-SPE2DB24FS62H
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The order has a potential value of $1,891.09 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of a pharmaceutical product - VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. This contract has a potential value of $7,125.13 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not a set-aside contract. The company also holds an indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a for-profit pharmaceutical distributor. The $2,825.20 firm fixed-price contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medication. The contract has a ceiling value of $2,825.20 and a completion date of September 10, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563589162 VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. The contract has a potential value of $3,687.60 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The contract, which has a potential value of $2,838.72, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the sole prime contractor on this award, which is not set aside for any small business or disadvantaged business designations. In...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $8,550.85 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. This order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the delivery of 4,564,803,529 units of the pharmaceutical product VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The fixed-price delivery order, valued at $2,205.95, has a completion date of June 5, 2024. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,419.36 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. This award is part of a broader indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00, to deliver a wide range of pharmaceuticals and medical supplies in support of the Department of Defense's military...
- The U.S. Department of Defense (DoD) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals. The contract has a ceiling value of $8,475.48 and a performance period through April 10, 2024. This delivery order was issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the Defense Logistics Agency (DLA) Troop Support...
- This federal contract award, valued at $15,737.53, was granted to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The contract has an ultimate completion date of August 27, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS62HDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The contract has a potential value of $7,528.10 and a completion date of February 20, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 2/16/24 |